阿苯達唑治療肝細粒棘球蚴病的系統評價_《中國循證醫學雜志》

作者：

王濤 ¹² , 劉雅莉 ¹³ ,  楊克虎 ¹³ , 金鳳玲 ⁴ , 景濤 ⁵ , 曹農 ⁶ , 田金徽 ¹³ , 馬彬 ¹³ , 楊林 ⁷

1. 蘭州大學循證醫學中心（蘭州 730000）2. 青島大學醫院（青島 266071）3. 蘭州大學循證醫學研究所（蘭州 730000）4. 蘭州大學第一醫院檢驗科（蘭州730000）5. 蘭州大學病原生物學研究所（蘭州730000）6. 蘭州大學第一醫院普外科（蘭州730000）7. 蘭州理工大學生命科學與工程學院（蘭州 730050）;

關鍵詞：

肝細粒棘球蚴病阿苯達唑系統評價

視頻：

導出 下載 收藏 掃碼 引用

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

目的　系統評價阿苯達唑治療肝細粒棘球蚴病（HCE）的療效。
方法　通過計算機檢索和手工檢索，全面收集阿苯達唑治療HCE的隨機和半隨機對照試驗，按Cochrane協作網推薦的方法進行分析。
結果　僅2個試驗符合納入標準，其方法學質量評價均為“B”級。1個研究比較了阿苯達唑與甲苯達唑治療HCE的療效，結果顯示其包囊數和病例數的有效率，兩組差異均無統計學意義［RR 1.19，95%CI（0.97，1.46）；RR 1.35，95%CI（0.91，2.00）］。另一個研究比較了阿苯達唑聯合手術與單純手術治療HCE的療效，結果顯示，阿苯達唑治療1月再手術與直接手術療效比較差異無統計學意義［RR 1.63，95%CI（0.90，2.93）］，阿苯達唑治療3月再手術與直接手術療效比較差異有統計學意義[RR 1.89，95%CI（1.09，3.29）］。
結論　① 阿苯達唑與甲苯達唑治療HCE的療效相似；② 阿苯達唑聯合手術治療與單純手術治療相比，阿苯達唑治療療程應足夠長（3個月）才會顯示出聯合治療的優越性。但由于本系統評價納入試驗數和病例數較少，測量指標不全面，因此會影響到上述結論的強度。要確定阿苯達唑治療HCE的效果，尚需開展更多高質量試驗。

引用本文： 王濤,劉雅莉,楊克虎,金鳳玲,景濤,曹農,田金徽,馬彬,楊林. 阿苯達唑治療肝細粒棘球蚴病的系統評價. 中國循證醫學雜志, 2007, 07(11): 789-793. doi: 復制

1.	Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54.
2.	Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134．.
3.	CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013.
4.	Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68.
5.	Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229.
6.	Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952.
7.	Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343.
8.	溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產物的含量. 地方病通報, 1989, 4(4): 52-54.
9.	柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國寄生蟲學與寄生蟲病雜志, 2001, 19(3): 129-134．.
10.	國家技術監督局, 中華人民共和國衛生部. 包蟲病診斷標準及處理原則. 中華人民共和國國家標準, 1997, GB7013.
11.	譚家忠, 王龍文. 阿苯達唑長期治療肝包蟲的臨床觀察. 地方病通報. 1995, 10(1): 67-68.
12.	張賀玲, 朱其銀, 荊強, 等. 兩種劑型阿苯達唑治療肝囊型包蟲病的療效對照觀察, 中國寄生蟲病防治雜志, 2002, 15(4): 228-229.
13.	Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694.
14.	Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536.
15.	Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035.
16.	Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388.
17.	Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508.
18.	Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717.
19.	Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459.
20.	Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309.
21.	Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133.
22.	Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66.
23.	Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272.

1. Wen H, Yao BL, Zou PF, et al. Determination of albendazole and RTS metabolites in serum bile and cystic fluid by HPLC. Endemic Disease Bulletin, 1989, 4(4): 52-54.
2. Chai JJ, Meng HB, Jiao W, et al. Efficacy of ablendazole emulsion in treatment of 212 patients with cystic echinococcosis. Chinese Journal of Parasitology and Parasitic Diseases, 2001, 19(3): 129-134．.
3. CSBTS, MOH. Diagnostic criteria and treatment principle of echinococcosis. The National Standards of the People’s Republic of China, 1997, GB7013.
4. Tan JZ, Wang LW. Observision of clinical curative effect with abendazole longer therapy in hydatid disease, edemic aviso. Endemic Disease Bulletin, 1995, 10(1): 67-68.
5. Zhang HL, Zhu QY, Jiing Q, et al. A comparative trial of clinical efficacy of emulsion albendazole in treatment of hepatic cystic echinococcosis. Chinese Journal of Parasitic Disease Control, 2002, 15(4): 228-229.
6. Qian XM. Progress in surgical treatment of hydatid disease in China clinical analysis of 2005 surgical case. Chinese Medical Journal, 1995, 108(4): 2952.
7. Wen H, Zou PF, Yang WG, et al. Abendazole chemotherapy for human cystic and alveolar echinococcosis in Northwestern China. Trans Rsoc Trop MedHyg, 1994, 340-343.
8. 溫浩, 姚秉禮, 鄒培范, 等. 高效液相色譜法測定人體血液膽汁和包蟲囊液的丙硫咪唑及代謝產物的含量. 地方病通報, 1989, 4(4): 52-54.
9. 柴君杰, 孟賀巴特, 焦偉, 等. 阿苯達唑乳劑治療肝囊型包蟲病212例臨床療效觀察. 中國寄生蟲學與寄生蟲病雜志, 2001, 19(3): 129-134．.
10. 國家技術監督局, 中華人民共和國衛生部. 包蟲病診斷標準及處理原則. 中華人民共和國國家標準, 1997, GB7013.
11. 譚家忠, 王龍文. 阿苯達唑長期治療肝包蟲的臨床觀察. 地方病通報. 1995, 10(1): 67-68.
12. 張賀玲, 朱其銀, 荊強, 等. 兩種劑型阿苯達唑治療肝囊型包蟲病的療效對照觀察, 中國寄生蟲病防治雜志, 2002, 15(4): 228-229.
13. Mohamed AE, Yasawy MI, Al-Karawi MA. Combined albendazole and praziquantel versus albendazole alone in the treatment of hydatid disease. Hepatogastroenterology, 1998, 45(23): 1690-1694.
14. Gupta SK, Schantz PM, Donaldson JS. Recurrent hydatid disease after therapy with albendazole. Pediatr Infect Dis J, 1993, 12(6): 535-536.
15. Morris DL, Taylor. Sensitivity to albendazole sulphoxide of echinococcus granulosus scoleces in man. Lancet, 1986, 2(8514): 1035.
16. Davis A, Pawlowski ZS, Dixon H. Multicetre clinical trials of benzimidazole carbamates in human echinococcosis. Bulletin of the World Health Organization, 1986, 64(3): 383-388.
17. Davis A, Dixon H, Pawlowski ZS. Multicetre clinical trials of benzimidazole carbamates in human cystic echinococcosis (phase 2). Bulletin of the World Health Organization, 1989, 67(5): 503-508.
18. Wilcox MH, Morris DL, Bailey JW. Serology in patients treated with albendazole for hydatid disease. J R Soc Med, 1988, 81(12): 714-717.
19. Mohammed SK, Yousuf D, Ghulam NY. Percutaneous drainage versus albendazole therapy in hepatic hydatidosis: a prospective, randomized study. Gastroenterology, 1993, 104: 1452-1459.
20. Cristiana F, Bruno DV, Antonella T. Long-Term Evaluation of Patients with Hydatidosis Treated with Benzimidazole Carbamates. Clinical Infectious Diseases, 1999, 29: 304-309.
21. Evangelos C, Tsimoyiannis PS, Kyriaki J. Moutesidou.Periopertive Benzimidazole Therapy in Human Hydaid Liver Disease. Int Surg, 1995, 80: 131-133.
22. Byt Todorov K, Vutova G, Mechkov P. Georgiev. Chemotherapy of human cystic echinococcosis: comparative efficacy of mebendazole and albendazole. Annals of Tropical Medicine and Parasitology, 1992, 86(1): 59-66.
23. Gil-Grande LA, Rodriguez-Caabeiro F, Prieto JG, et al. Randomised controlled trial of efficacy of albendazole in intra-abdominal hydatid disease. Lancet, 1993, 342(8882): 1269-1272.

《中國循證醫學雜志》

阿苯達唑治療肝細粒棘球蚴病的系統評價

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

《中國循證醫學雜志》

阿苯達唑治療肝細粒棘球蚴病的系統評價

摘要 全文 圖表 視頻 參考文獻 施引文獻 補充材料

Format

Content

摘要全文圖表視頻參考文獻施引文獻補充材料